Pamela A Carroll, Age 54Jamison, PA

Pamela Carroll Phones & Addresses

Jamison, PA

82 Colleen Cir, Trenton, NJ 08638

Ewing, NJ

Buck, PA

Pennington, NJ

Plainsboro, NJ

Madison, NJ

Show more

Work

Company: Abington Memorial Hospital Address: 1200 Old York Road, Abington, PA 19001

Languages

English

Mentions for Pamela A Carroll

Professional Records

Medicine doctors

Pamela Carroll Photo 1

Dr. Pamela T Carroll, Abington PA - MD (Doctor of Medicine)

Specialties:
Obstetrics & Gynecology
Address:
1200 Old York Rd, Abington, PA 19001
(215) 481-2000 (Phone)
Languages:
English
Hospitals:
1200 Old York Rd, Abington, PA 19001
Abington Memorial Hospital
1200 Old York Road, Abington, PA 19001
Pamela Carroll Photo 2

Pamela Tennille Carroll

Specialties:
Obstetrics & Gynecology
Pamela Carroll Photo 3

Pamela T Carroll, Abington PA

Specialties:
OB-GYN
Address:
1200 Old York Rd, Abington, PA 19001

Resumes

Resumes

Pamela Carroll Photo 4

Pamela Carroll

Location:
United States
Work:
Independent - United States Jun 2012 - Jun 2013
Consultant
HCA Sep 1995 - Mar 2012
CNO
All About Staffing - Tampa/St. Petersburg, Florida Area 2003 - 2005
Regional Vice President
Notth Broward hospital district Jun 1978 - Sep 1995
CNO
Pamela Carroll Photo 5

Biotechnology External Compliance Lead At Monsanto

Location:
Davis, California
Industry:
Biotechnology
Work:
Monsanto May 2010 - Jun 2011
Trait Development External Compliance Lead
Monsanto Jan 2008 - Nov 2010
Molecular Biologist
Geno-Type Biotechnology Oct 2005 - Jan 2008
Director of Operations
King Faisal Specialist Hospital 2001 - 2005
Scientific Coordinator and Laboratory Manager
Large Scale Biology Corporation 1999 - 2001
Research Scientist
Gladstone Instsitutes 1995 - 1996
Research Associate
Progenesys/SyStemix 1994 - 1995
Research Associate
SyStemix 1994 - 1995
Research Associate
Education:
University of California, Davis 1990 - 1994
Pamela Carroll Photo 6

Pamela Carroll

Location:
Greater Philadelphia Area
Industry:
Management Consulting
Pamela Carroll Photo 7

Pamela Carroll

Location:
United States
Pamela Carroll Photo 8

Pamela Carroll

Location:
United States

Business Records

Name / TitleCompany / ClassificationPhones & Addresses
Pamela Tennille Carroll Pamela Carroll MD 1200 Old York Rd, Abington, PA 19001
(215) 481-6784

Publications

US Patents

Novel Drosophila Tumor Necrosis Factor Class Molecule ( Dmtnf ) And Variants Thereof

US Patent:
2002001, Jan 31, 2002
Filed:
Mar 20, 2001
Appl. No.:
09/813329
Inventors:
Pamela Carroll - Princeton NJ,
Jian Chen - Princeton NJ,
Chandra Ramanathan - Wallingford CT,
Hong Xiao - Princeton Junction NJ,
Bo Guan - Princeton NJ,
Michael Bowen - Lawrenceville NJ,
International Classification:
G01N033/53
A01K067/033
C12P021/02
C12N005/06
C07K014/52
US Classification:
435/069500, 435/348000, 530/351000, 800/013000, 435/007100
Abstract:
The present invention provides novel polynucleotides encoding Drosophila DmTNF polypeptides, fragments and homologs thereof. The present invention also is directed to novel polynucleotides encoding two Drosophila DmTNF variants, DmTNFv1 and DmTNFv2 polypeptides, fragments and homologs thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention, in addition to methods of genetically modifying Drosophila or cultured cells to express or mis-express DmTNF, DmTNFv1, or DmTNFv2. The invention also relates to the use of such modified insects or cells to characterize DmTNF activity, identify TNF-like genes and/or genes implicated in modulating TNF, characterize TNF signaling pathways, and/or to identify modulators of DmTNF activity.

Polynucleotide Encoding A Novel Human Potassium Channel Beta-Subunit, K+Betam2

US Patent:
2003003, Feb 13, 2003
Filed:
Jan 24, 2002
Appl. No.:
10/056884
Inventors:
Han Chang - Princeton Junction NY,
Jian Chen - Princeton NJ,
John Feder - Belle Mead NJ,
Donald Jackson - Lawrenceville NJ,
Liana Lee - North Brunswick NJ,
Chandra Ramanathan - Wallingford CT,
Nathan Siemers - Pennington NJ,
Pamela Carroll - Princeton NJ,
International Classification:
C07H021/02
C07H021/04
US Classification:
536/023100
Abstract:
The present invention provides novel polynucleotides encoding K+betaM2 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel K+betaM2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Polynucleotide Encoding Two Novel Human Potassium Channel Beta-Subunits, K+Betam4 And K+Betam5

US Patent:
2003005, Mar 20, 2003
Filed:
Feb 28, 2002
Appl. No.:
10/086156
Inventors:
John Feder - Belle Mead NJ,
Liana Lee - North Brunswick NJ,
Jian Chen - Princeton NJ,
Donald Jackson - Lawrenceville NJ,
Chandra Ramanathan - Wallingford CT,
Nathan Siemers - Pennington NJ,
Han Chang - Princeton Junction NJ,
Pamela Carroll - Princeton NJ,
International Classification:
A61K038/17
C07K014/435
C12P021/02
C12N005/06
US Classification:
514/012000, 530/350000, 536/023500, 435/069100, 435/325000, 435/320100
Abstract:
The present invention provides novel polynucleotides encoding K+betaM4 or K+betaM5 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel K+betaM4 or K+betaM5 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Polynucleotide Encoding A Novel Human Potassium Channel Beta-Subunit, K+Betam3

US Patent:
2003011, Jun 19, 2003
Filed:
Feb 7, 2002
Appl. No.:
10/071458
Inventors:
John Feder - Belle Mead NJ,
Liana Lee - North Brunswick NJ,
Jian Chen - Princeton NJ,
Donald Jackson - Lawrenceville NJ,
Chandra Ramanathan - Wallingford CT,
Nathan Siemers - Pennington NJ,
Han Chang - Princeton Junction NJ,
Rolf-Peter Ryseck - Ewing NJ,
Andrew Watson - West Windsor NJ,
Pamela Carroll - Princeton NJ,
International Classification:
A61K038/17
C07K014/435
C12P021/02
C12N005/06
C07H021/04
US Classification:
514/012000, 530/350000, 536/023500, 435/069100, 435/320100, 435/325000
Abstract:
The present invention provides novel polynucleotides encoding K+betaM3 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel K+betaM3 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Modulators Of Rabggt And Methods Of Use Thereof

US Patent:
2004014, Jul 22, 2004
Filed:
Aug 7, 2003
Appl. No.:
10/638225
Inventors:
Veeraswamy Manne - Philadelphia PA,
Mark Lynch - Madison CT,
Petra Ross-MacDonald - Pennington NJ,
Terry Stouch - West Windsor NJ,
Naomi Laing - Stoneham MA,
Pamela Carroll - Princeton NJ,
Kevin Fitzgerald - Lambertville NJ,
Louis Lombardo - Belle Mead NJ,
Michael Costa - San Francisco CA,
Mark Maxwell - San Francisco CA,
Rachel Kindt - San Carlos CA,
Mark Lackner - Brisbane CA,
Tak Hung - Foster City CA,
Carol O'Brian - Castro Valley CA,
Hai Zhang - El Sobrante CA,
Katherine Brown - San Francisco CA,
Jae Lee - Cupertino CA,
International Classification:
A61K048/00
G01N033/574
A61K031/5513
A61K031/47
US Classification:
514/044000, 514/221000, 514/310000, 435/007230
Abstract:
The present invention provides methods for inducing apoptosis in a cell, the methods generally involving contacting the cell with an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for treating a disorder related to unwanted cell proliferation in an individual, the methods generally involving administering to the individual an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for reducing apoptosis in a cell, the methods generally involving increasing the level and/or activity of RabGGT in the cell. The present invention further provides methods for treating disorders associated with excessive apoptosis. The present invention further provides methods for identifying a cell that is amenable to treatment with the methods of the present invention. The present invention further provides methods for modulating a binding event between RabGGT and a RabGGT interacting protein. The present invention further provides a 3-dimensional structure of RabGGT, and methods of use of the structure to identify compounds that modulate RabGGT activity.

Novel Drosophila Tumor Necrosis Factor Class Molecule ("dmtnf") And Variants Thereof

US Patent:
2006014, Jul 6, 2006
Filed:
Feb 1, 2006
Appl. No.:
11/345126
Inventors:
Pamela Carroll - Princeton NJ,
Jian Chen - Princeton NJ,
Chandra Ramanathan - Wallingford CT,
Hong Xiao - Princeton Junction NJ,
Bo Guan - Princeton NJ,
Michael Bowen - Lawrenceville NJ,
International Classification:
C12Q 1/68
C07H 21/04
C12P 21/02
C07K 14/525
C12N 5/06
US Classification:
435006000, 435069500, 435320100, 435348000, 530351000, 536023500
Abstract:
The present invention provides novel polynucleotides encoding DmTNF polypeptides, fragments and homologs thereof. The present invention also is directed to novel polynucleotides encoding two DmTNF variants, DmTNFv1 and DmTNFv2 polypeptides, fragments and homologs thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention, in addition to methods of genetically modifying or cultured cells to express or mis-express DmTNF, DmTNFv1, or DmTNFv2. The invention also relates to the use of such modified insects or cells to characterize DmTNF activity, identify TNF-like genes and/or genes implicated in modulating TNF, characterize TNF signaling pathways, and/or to identify modulators of DmTNF activity.

Drosophila Tumor Necrosis Factor Class Molecule ("dmtnfv2")

US Patent:
2005022, Oct 13, 2005
Filed:
Jun 1, 2005
Appl. No.:
11/142736
Inventors:
Pamela Carroll - Princeton NJ,
Jian Chen - Princeton NJ,
Chandra Ramanathan - Wallingford CT,
Hong Xiao - Princeton Junction NJ,
Bo Guan - Princeton NJ,
Michael Bowen - Lawrenceville NJ,
International Classification:
C12Q001/68
C07H021/04
C12N015/09
C07K014/525
US Classification:
435006000, 435069500, 435348000, 435320100, 530351000, 536023500
Abstract:
The present invention provides novel polynucleotides encoding DmTNF polypeptides, fragments and homologs thereof. The present invention also is directed to novel polynucleotides encoding two DmTNF variants, DmTNFv1 and DmTNFv2 polypeptides, fragments and homologs thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention, in addition to methods of genetically modifying or cultured cells to express or mis-express DmTNF, DmTNFv1, or DmTNFv2. The invention also relates to the use of such modified insects or cells to characterize DmTNF activity, identify TNF-like genes and/or genes implicated in modulating TNF, characterize TNF signaling pathways, and/or to identify modulators of DmTNF activity.

ISBN (books and publications)

Integrated Literacy Instruction In The Middle Grades: Channeling Young Adolescents Spontaneous Overflow Of Energy

Author:
Pamela S. Carroll
ISBN #:
0205375545

Using Literature To Help Troubled Teenagers Cope With Societal Issues

Author:
Pamela S. Carroll
ISBN #:
0313305269

13 Ways Of Looking At Student Teaching: A Guide For First-Time English Teachers

Author:
Pamela S. Carroll
ISBN #:
0325005516

Caroline Cooney: Faith And Fiction

Author:
Pamela S. Carroll
ISBN #:
0810840685

Books And Beyond: Thematic Approaches For Teaching Literature In High School

Author:
Pamela S. Carroll
ISBN #:
0926842722

Integrated Literacy Instruction In The Middle Grades: Channeling Young Adolescents' Spontaneous Overflow Of Energy, Mylabschool Edition

Author:
Pamela Sissi Carroll
ISBN #:
0205463681

Sharon Creech

Author:
Pamela Sissi Carroll
ISBN #:
0313335982

The Dolphins And Me

Author:
Pamela Carroll
ISBN #:
0316736597

All data offered is derived from public sources. We do not verify or evaluate each piece of data, and makes no warranties or guarantees about any of the information offered. We do not possess or have access to secure or private financial information. People Background Check is not a credit reporting agency and does not offer consumer reports. None of the information offered by People Background Check is to be considered for purposes of determining any entity or person's eligibility for credit, insurance, employment, housing, or for any other purposes covered under the FCRA.